top of page

Reporting & Project Management

UHP is managing complex interactions with different stakeholders within the health system

patient advocacy.png

Patient Advocacy Groups

approval agencies.png

CRO & CMO

clinical research.png

Approval agencies

pharma.png
insurances.png

UHP provides the high-quality data basis for successful reimbursement negotiations. UHP's consults partners on the optimal design of the product label in preparation of a succesful commercialization.

UHP supports in the study design and execution in a clinical research setting together with CROs, CMOs and other research organizations.

UHP is in close interaction with patient advocacy groups to foster a patient-centric service design.

Pharma & Biotech

Insurances

UHP provides consulting and hands-on solutions for all phases of the product lifecycle. Through our holistic support services, we make your product a success - from Clinical Study over Early Access Programme to Launch & Market Entry Support.

UHP is well-connected with insurance companies and assist with individual reimbursement negotiations.

Our support along the entire product lifecycle

Clinical Development

Blue line.png
Blue line.png

In the clinical development phase, UHP can support with the design of the study protocol. By activating the relevant Key Opinion Leaders and research centers, we help accelerate the recruitment of suitable patients for your clinical program.

Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png

Early Access Program

Blue line.png
Blue line.png

We help make your medicine available to selected patients across the entire EU by organizing the launch of the Early Access Program. This includes the product import & distribution, submission of EAP dossiers and interaction with KOLs.

Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png

Commercial Roll-out

In-depth understanding of the orphan drug market and an outstanding medical network help make your product launch a success. UHP accompanies the seamless transition from EAP to commercialization and delivers high-quality data to support reimbursement negotiations for your product.

Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png

Market Penetration

Blue line.png
Blue line.png

The market for rare disease therapies can be highly competitive and innovative treatments might face severe hurdles. UHP is there to co-design a strategy to address these challenges and help differentiate your product in the market.

Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png

Lifecycle Management

Our holistic, patient-centered services are designed to stay. Through close care, we are increasing adherence as well as long-term patient retention on therapy in the extended product lifecycle.

Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
Blue line.png
11.03.2022.16-UHP.png

Data Reporting & Real World Evidence

Along the entire value chain from manufacturer to patient's home, UHP has access to an extensive set of data points. Together with our partners, we define relevant KPIs that allow creating unique insights and improve the patient experience. Patient data is handled with the utmost care and all data reports are fully compliant with applicable data protection laws.

CONTACT US

United Healthcare Partners

Blegistrasse 11b

6341, Baar

Switzerland

contact@united-hp.com

+49 (0) 2161 6398271

Thanks for submitting!

bottom of page